SEC Comment Letter for Canton Strategic Holdings, (CNTN) — Jan 14, 2026
Canton Strategic Holdings, Inc.
Date: Jan. 14, 2026 · CIK: 0001861657 · Accession: 0000000000-26-000480
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-292648
Letter
Re: Tharimmune, Inc. Registration Statement on Form S-3 Filed January 9, 2026 File No. 333-292648 Dear Mark Wendland:
January 14, 2026
Mark Wendland Chief Executive Officer Tharimmune, Inc. 34 Shrewsbury Avenue, Suite 1C Red Bank, NJ 07701
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Lauren Hamill at 303-844-1008 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Yuta Delarck
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> January 14, 2026 Mark Wendland Chief Executive Officer Tharimmune, Inc. 34 Shrewsbury Avenue, Suite 1C Red Bank, NJ 07701 Re: Tharimmune, Inc. Registration Statement on Form S-3 Filed January 9, 2026 File No. 333-292648 Dear Mark Wendland: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Lauren Hamill at 303-844-1008 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Yuta Delarck </TEXT> </DOCUMENT>